Portfolio Companies
Sort By:
Aptinyx
Neurology | Clinical | IPO
Clinical company developing platform of neuromodulators for neurology indications.
×
Carisma Therapeutics
Carisma Therapeutics
Oncology | Clinical | Active
Preclinical company developing immunotherapy platform for oncology applications.
×
Dice Molecules
Dice Molecules
Oncology, Immunology | Preclinical | Active
Preclinical company bringing directed chemical evolution to small molecule drug discovery.
×
Dragonfly Therapeutics
Dragonfly Therapeutics
Oncology, Immunology | Clinical | Active
Clinical stage company targeting Natural Killer cells for immuno-oncology applications.
×
×
Entrada Therapeutics
Entrada Therapeutics
Rare Disease | Preclinical | Active
×
Freenome
Freenome
Oncology | Clinical | Active
Clinical stage company using AI genomics for early cancer detection.
×
ImCheck Therapeutics
ImCheck Therapeutics
Oncology | Clinical | Active
Clinical stage company developing novel immuno-oncology antibodies targeting gamma delta T-cells.
×
Interius BioTherapeutics
Interius BioTherapeutics
Oncology | Preclinical | Active
Preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
×
×
Metagenomi
Metagenomi
Rare Disease, Oncology, Immunology | Preclinical | Active
Preclinical stage company discovering breakthrough gene editing systems for curing disease.
×
Orbus Therapeutics
Orbus Therapeutics
Oncology | Clinical | Active
Clinical company developing therapeutics for rare brain tumors.
×
Orchard Therapeutics
Orchard Therapeutics
Rare Disease, Neurology, Immunology | Commercial | IPO
Commercial company developing gene therapies for rare immunology disorders.
×
Palvella Therapeutics
Palvella Therapeutics
Rare Disease, Immunology | Clinical | Active
Clinical stage company developing therapeutics for rare dermatological disorders.
×
×
Pliant Therapeutics
Pliant Therapeutics
Rare Disease | Clinical | IPO
Clinical stage company developing therapeutics targeting key biological pathways in fibrosis.
×
Precision Biosciences
Precision Biosciences
Rare Disease, Oncology | Clinical | IPO
Clinical stage company developing gene-editing platform for oncology and rare diseases.
×
Pyxis Oncology
Pyxis Oncology
Oncology | Preclinical | Active
Preclinical company developing antibody-based immunotherapies.
×
Skyhawk Therapeutics
Skyhawk Therapeutics
Rare Disease, Oncology, Neurology | Preclinical | Active
Preclinical company developing platform to correct RNA expression in neurology, oncology and rare diseases.
×
×
×